Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2007 1
2008 1
2009 1
2010 2
2011 5
2012 7
2013 5
2014 2
2015 2
2016 8
2017 9
2018 9
2019 7
2020 12
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Mutant NPM1 Maintains the Leukemic State through HOX Expression.
Brunetti L, Gundry MC, Sorcini D, Guzman AG, Huang YH, Ramabadran R, Gionfriddo I, Mezzasoma F, Milano F, Nabet B, Buckley DL, Kornblau SM, Lin CY, Sportoletti P, Martelli MP, Falini B, Goodell MA. Brunetti L, et al. Among authors: milano f. Cancer Cell. 2018 Sep 10;34(3):499-512.e9. doi: 10.1016/j.ccell.2018.08.005. Cancer Cell. 2018. PMID: 30205049 Free PMC article.
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.
Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, Horwitz M, Milano F, Olson A, Spellman S, Wagner JE, Delaney C, Shpall E. Barker JN, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2017 Jun;23(6):882-896. doi: 10.1016/j.bbmt.2017.03.006. Epub 2017 Mar 6. Biol Blood Marrow Transplant. 2017. PMID: 28279825 Free PMC article. Review.
Unrelated donor cord blood transplantation (CBT) results in disease-free survival comparable to that of unrelated adult donor transplantation in patients with hematologic malignancies. ...Targeted care strategies in CBT recipients can mitigate early transplantati
Unrelated donor cord blood transplantation (CBT) results in disease-free survival comparable to that of unrelated adult donor tran
Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy.
Shadman M, Gauthier J, Hay KA, Voutsinas JM, Milano F, Li A, Hirayama AV, Sorror ML, Cherian S, Chen X, Cassaday RD, Till BG, Gopal AK, Sandmaier BM, Maloney DG, Turtle CJ. Shadman M, et al. Among authors: milano f. Blood Adv. 2019 Oct 22;3(20):3062-3069. doi: 10.1182/bloodadvances.2019000593. Blood Adv. 2019. PMID: 31648329 Free PMC article.
Allogeneic hematopoietic cell transplantation (allo-HCT) is offered to selected patients after chimeric antigen receptor-modified T-cell (CAR-T) therapy. ...
Allogeneic hematopoietic cell transplantation (allo-HCT) is offered to selected patients after chimeric antigen receptor-modified T-c …
Guidelines for Cord Blood Unit Selection.
Politikos I, Davis E, Nhaissi M, Wagner JE, Brunstein CG, Cohen S, Shpall EJ, Milano F, Scaradavou A, Barker JN; American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. Politikos I, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2020 Dec;26(12):2190-2196. doi: 10.1016/j.bbmt.2020.07.030. Epub 2020 Jul 28. Biol Blood Marrow Transplant. 2020. PMID: 32736011
Optimal cord blood (CB) unit selection is critical to maximize the likelihood of successful engraftment and survival after CB transplantation (CBT). However, unit selection can be complex because multiple characteristics must be considered including unit cell dose, donor-r …
Optimal cord blood (CB) unit selection is critical to maximize the likelihood of successful engraftment and survival after CB transplanta
Cord-Blood Transplantation in Patients with Minimal Residual Disease.
Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, Witherspoon R, Mielcarek M, Deeg JH, Sorror M, Dahlberg A, Sandmaier BM, Salit R, Petersdorf E, Appelbaum FR, Delaney C. Milano F, et al. N Engl J Med. 2016 Sep 8;375(10):944-53. doi: 10.1056/NEJMoa1602074. N Engl J Med. 2016. PMID: 27602666 Free PMC article. Clinical Trial.
BACKGROUND: The majority of patients in need of a hematopoietic-cell transplant do not have a matched related donor. Data are needed to inform the choice among various alternative donor-cell sources. ...CONCLUSIONS: Our data suggest that among patients with pretransplantat …
BACKGROUND: The majority of patients in need of a hematopoietic-cell transplant do not have a matched related donor. Data are needed …
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, D'Souza A, Milano F, Phelan R, Saber W, Shaw BE, Weisdorf D, Devine SM, Horowitz MM. Hamadani M, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2020 Jul;26(7):1312-1317. doi: 10.1016/j.bbmt.2020.04.001. Epub 2020 Apr 10. Biol Blood Marrow Transplant. 2020. PMID: 32283185 Free PMC article.
Post-transplantation cyclophosphamide (ptCY) is an increasingly used approach for graft-versus-host disease (GVHD) prophylaxis, but the impact of graft cryopreservation on the outcomes of allo-HCT using ptCY is not known. Using the Center for International Blood and Marrow …
Post-transplantation cyclophosphamide (ptCY) is an increasingly used approach for graft-versus-host disease (GVHD) prophylaxis, but t …
Reply to Author.
Hill JA, Pergam SA, Boeckh M, Milano F. Hill JA, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2018 Oct;24(10):2166. doi: 10.1016/j.bbmt.2018.06.030. Epub 2018 Jun 30. Biol Blood Marrow Transplant. 2018. PMID: 29969748 Free article. No abstract available.
Guidelines for Cord Blood Unit Thaw and Infusion.
Scaradavou A, Avecilla ST, Tonon J, Politikos I, Horwitz ME, Kurtzberg J, Milano F, Barker JN; American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. Scaradavou A, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2020 Oct;26(10):1780-1783. doi: 10.1016/j.bbmt.2020.06.018. Epub 2020 Jun 27. Biol Blood Marrow Transplant. 2020. PMID: 32599214 No abstract available.
Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies.
Xue E, Milano F. Xue E, et al. Among authors: milano f. F1000Res. 2020 Jan 17;9:F1000 Faculty Rev-26. doi: 10.12688/f1000research.20605.1. eCollection 2020. F1000Res. 2020. PMID: 31984133 Free PMC article. Review.
Since the first hematopoietic stem cell transplant, over a million transplants have been performed worldwide. In the last decade, the transplant field has witnessed a progressive decline in bone marrow and cord blood utilization and a parallel increase in per …
Since the first hematopoietic stem cell transplant, over a million transplants have been performed worldwide. In the last deca …
Cord blood transplantation: rewind to fast forward.
Dahlberg A, Milano F. Dahlberg A, et al. Among authors: milano f. Bone Marrow Transplant. 2017 Jun;52(6):799-802. doi: 10.1038/bmt.2016.336. Epub 2016 Dec 19. Bone Marrow Transplant. 2017. PMID: 27991893 Review.
The utilization of cord blood as a source of stem cells for transplantation has decreased in recent years. Although cord blood transplantation (CBT) is an established practice for the treatment of adult and pediatric patients with hematological malignancies, the hig …
The utilization of cord blood as a source of stem cells for transplantation has decreased in recent years. Although cord blood tra
60 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page